Abiomed, Inc.ABMDNASDAQ
Loading
Cash Flow PerformanceStrong
Percentile Rank93
3Y CAGR+4.2%
5Y CAGR+19.9%
Studio
Year-over-Year Change

Cash generated from core business operations

3Y CAGR
+4.2%/yr
vs +55.4%/yr prior
5Y CAGR
+19.9%/yr
Recent deceleration
Acceleration
-51.2pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2022$285.39M+3.9%
2021$274.58M-12.8%
2020$314.92M+24.9%
2019$252.20M+31.0%
2018$192.55M+67.3%
2017$115.12M+49.9%
2016$76.80M+77.4%
2015$43.29M+84.5%
2014$23.47M-11.1%
2013$26.40M-